Other OTC - Delayed Quote USD

Cyclo3pss Corporation (CYPS)

0.0000 0.0000 (0.00%)
At close: January 10 at 2:40 PM EST
Loading Chart for CYPS
DELL
  • Previous Close 0.0000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.0001
  • Volume 1,500
  • Avg. Volume 0
  • Market Cap (intraday) 40
  • Beta (5Y Monthly) 33.79
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0240
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Cyclo3pss Corporation engages in the licensing, manufacture, sale, and installation of ozone food processing products; and ozone washing and laundry sorting and counting systems for commercial and institutional laundries. It also engages in the research and development of technologies for the sterilization and/or disinfection of certain consumer products. The company was founded in 1927 and is based in Salt Lake City, Utah. In July 2002, the Board of Directors of Cyclo3pss determined to suspend all operations of the company immediately due to an inability to locate willing investors and to secure necessary and suitable financing.

4

Full Time Employees

February 28

Fiscal Year Ends

Related News

Performance Overview: CYPS

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CYPS
99.00%
S&P 500
5.84%

1-Year Return

CYPS
95.00%
S&P 500
22.03%

3-Year Return

CYPS
99.98%
S&P 500
20.77%

5-Year Return

CYPS
99.93%
S&P 500
72.46%

Compare To: CYPS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CYPS

Valuation Measures

Annual
As of 4/2/2024
  • Market Cap

    4.05k

  • Enterprise Value

    4.05k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -232.29%

  • Return on Assets (ttm)

    -235.75%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    366.01k

  • Net Income Avi to Common (ttm)

    -1.08M

  • Diluted EPS (ttm)

    -0.0240

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    73.1k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -521.83k

Company Insights: CYPS